Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
Health
Jane Kirby

Around 3,000 lives could be saved ‘by changes to heart failure treatment’

Changes to heart failure treatment could save lives, regulators have said. (Alamy/PA) -

Around 3,000 lives could be saved and 5,500 hospital admissions prevented each year by changes to how people are treated for heart failure, according to a watchdog.

New draft guidelines from the National Institute for Health and Care Excellence (Nice) recommend medicines are given up to a year earlier.

It has looked specifically at a type of heart failure called heart failure with a reduced ejection fraction (HFrEF), which happens when the left side of the heart fails to pump blood out to the body properly.

The condition affects around 387,000 of the 614,000 adults in England with heart failure.

Nice said medics are already changing practice to ensure that the four pillars of treatment – angiotensin-converting enzyme inhibitor (ACEI), a beta-blocker (BB), a mineralocorticoid receptor antagonist (MRA) and a sodium-glucose cotransporter-2 (SGLT2) inhibitor – can be used earlier without the need to optimise the dose of any one medicine before introducing another.

Nice is recommending widespread earlier use of the SGLT2 inhibitors empagliflozin and dapagliflozin – giving them at the start of treatment rather than waiting up to a year for dosage of other drugs to be optimised.

Generally, Nice said the drugs can also be started by GPs with advice from a heart failure specialist, rather than having to refer people to hospitals.

Eric Power, deputy director in Nice’s centre for guidelines, said: “Heart failure is common, with currently around 614,000 adults in England living with a diagnosis.

“Although there’s no cure, it is treatable, and the growing number of people living with heart failure is testament to the improvements in care introduced over recent years.

“For this update we’ve been able to review the emerging evidence quickly to keep pace with changes in the treatment landscape and make recommendations that will widen access to effective treatments.

“This should have a big impact on the lives of people living with heart failure as well as freeing up space in hospitals by reducing their risk of having to go to hospital for unplanned emergency treatment.”

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.